COMPANY

CERo Therapeutics

HQ: South San Francisco, CA source · cero.bio ↗

Keywords: oncology hematology hematologic malignancies solid tumors tumors

Location: South San Francisco, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

Jun 6, 2025 Raise Private equity round — Series D: $8M (up to, as announced), announced Jun 6, 2025. Source: company release on GlobeNewswire. source ↗
Apr 22, 2025 Raise Private equity round — Series D: $8M (up to, as announced), announced Apr 22, 2025. Source: company release on GlobeNewswire. source ↗

Raised: $16.0M. Last 2 years.

Jun 6, 2025 Private equity round — Series D: $8M (up to, as announced), announced Jun 6, 2025. Source: company release on GlobeNewswire. source ↗
Apr 22, 2025 Private equity round — Series D: $8M (up to, as announced), announced Apr 22, 2025. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2025-05-06 Raise Private raise (SEC Form D): $5.0M sold of $8.0M offered; issuer “CERO THERAPEUTICS HOLDINGS, INC.”. Verified from the SEC filing. SEC filing ↗